These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 16204045)
1. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045 [TBL] [Abstract][Full Text] [Related]
2. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Benoit GR; Flexor M; Besançon F; Altucci L; Rossin A; Hillion J; Balajthy Z; Legres L; Ségal-Bendirdjian E; Gronemeyer H; Lanotte M Mol Endocrinol; 2001 Jul; 15(7):1154-69. PubMed ID: 11435615 [TBL] [Abstract][Full Text] [Related]
4. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. Kamashev D; Vitoux D; De Thé H J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541 [TBL] [Abstract][Full Text] [Related]
5. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Duprez E; Lillehaug JR; Gaub MP; Lanotte M Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454 [TBL] [Abstract][Full Text] [Related]
17. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells. Idres N; Marill J; Chabot GG Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis. Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061 [TBL] [Abstract][Full Text] [Related]
19. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation. Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624 [TBL] [Abstract][Full Text] [Related]
20. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Lehmann S; Paul C; Törmä H Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]